These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Salbutamol induced hypokalaemia: the effect of theophylline alone and in combination with adrenaline. Whyte KF; Reid C; Addis GJ; Whitesmith R; Reid JL Br J Clin Pharmacol; 1988 May; 25(5):571-8. PubMed ID: 3408637 [TBL] [Abstract][Full Text] [Related]
4. Effects of beta 2-adrenoceptor stimulation on cardiac metabolism in the conscious dog. Shanahan EA; Wahlqvist ML; Wilmshurst EG Br J Pharmacol; 1979 Jun; 66(2):229-33. PubMed ID: 465875 [TBL] [Abstract][Full Text] [Related]
5. The metabolic actions of intravenous salbutamol and aminophylline singly and in combination. Jenkins CR; Marlin GE Br J Clin Pharmacol; 1981 Feb; 11(2):197-201. PubMed ID: 7011349 [TBL] [Abstract][Full Text] [Related]
6. The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential. Du Plooy WJ; Hay L; Kahler CP; Schutte PJ; Brandt HD Br J Pharmacol; 1994 Jan; 111(1):73-6. PubMed ID: 8012727 [TBL] [Abstract][Full Text] [Related]
7. Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease. Crane J; Burgess CD; Graham AN; Maling TJ N Z Med J; 1987 May; 100(824):309-11. PubMed ID: 3330186 [TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men. Leitch AG; Clancy LJ; Costello JF; Flenley DC Br Med J; 1976 Feb; 1(6006):365-7. PubMed ID: 1247857 [TBL] [Abstract][Full Text] [Related]
9. Is there a need to treat hypokalaemia associated with intravenous salbutamol infusion? Chua S; Razvi K; Wong MT; Tay R; Arulkumaran S J Obstet Gynaecol Res; 1997 Aug; 23(4):381-7. PubMed ID: 9311181 [TBL] [Abstract][Full Text] [Related]
10. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease. Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625 [TBL] [Abstract][Full Text] [Related]
11. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Scheinin M; Koulu M; Laurikainen E; Allonen H Br J Clin Pharmacol; 1987 Nov; 24(5):645-53. PubMed ID: 2829953 [TBL] [Abstract][Full Text] [Related]
12. Protection against severe hypokalemia but impaired cardiac repolarization after intense rowing exercise in healthy humans receiving salbutamol. Atanasovska T; Smith R; Graff C; Tran CT; Melgaard J; Kanters JK; Petersen AC; Tobin A; Kjeldsen KP; McKenna MJ J Appl Physiol (1985); 2018 Aug; 125(2):624-633. PubMed ID: 29745804 [TBL] [Abstract][Full Text] [Related]
13. Characterization of beta-adrenoceptor subtype mediating the metabolic actions of salbutamol. Berend N; Marlin GE Br J Clin Pharmacol; 1978 Mar; 5(3):207-11. PubMed ID: 207295 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the metabolic effects of salbutamol administered in a one-minute bolus and a continuous infusion in patients with bronchial asthma. Elegbeleye OO; Williams KO; Femi-Pearse D Isr J Med Sci; 1978 Apr; 14(4):455-8. PubMed ID: 669922 [TBL] [Abstract][Full Text] [Related]
15. Effects of hypokalaemia on arrhythmogenic risk of quinidine in rats. Hirota M; Ohtani H; Hanada E; Kotaki H; Sawada Y; Iga T Life Sci; 1998; 62(24):2159-69. PubMed ID: 9627074 [TBL] [Abstract][Full Text] [Related]
16. Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects. Lipworth BJ; Tregaskis BF; McDevitt DG Eur J Clin Pharmacol; 1991; 40(3):255-60. PubMed ID: 2060561 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the extent and duration of hypokalaemia following three nebulized beta 2-adrenoceptor agonists. Burgess CD; Flatt A; Siebers R; Crane J; Beasley R; Purdie G Eur J Clin Pharmacol; 1989; 36(4):415-7. PubMed ID: 2567672 [TBL] [Abstract][Full Text] [Related]
18. Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. Bennett JA; Tattersfield AE Thorax; 1997 May; 52(5):458-64. PubMed ID: 9176539 [TBL] [Abstract][Full Text] [Related]